Mutual of America Capital Management LLC Reduces Holdings in HCA Healthcare, Inc. $HCA

Mutual of America Capital Management LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,150 shares of the company’s stock after selling 53 shares during the period. Mutual of America Capital Management LLC’s holdings in HCA Healthcare were worth $8,869,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare during the second quarter worth approximately $27,000. Ameriflex Group Inc. acquired a new stake in HCA Healthcare during the second quarter worth approximately $27,000. Cheviot Value Management LLC acquired a new stake in HCA Healthcare during the first quarter worth approximately $26,000. Saudi Central Bank acquired a new stake in HCA Healthcare during the first quarter worth approximately $26,000. Finally, WPG Advisers LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $425.50 on Monday. The company has a 50-day moving average of $410.05 and a 200-day moving average of $378.63. The company has a market capitalization of $99.56 billion, a P/E ratio of 17.89, a PEG ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $439.01.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HCA. Cantor Fitzgerald reiterated an “overweight” rating and issued a $444.00 price target on shares of HCA Healthcare in a report on Tuesday, October 7th. Jefferies Financial Group lifted their target price on shares of HCA Healthcare from $400.00 to $485.00 in a report on Wednesday, October 15th. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a report on Tuesday, October 7th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Finally, Mizuho lifted their price target on shares of HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.